The Metabolic Landscape of Gynecological Cancer: Identifying Targets for Therapeutic Intervention
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (28 April 2025) | Viewed by 3485
Special Issue Editor
Special Issue Information
Dear Colleagues,
Gynecological cancer (comprised of ovarian/fallopian tube, primary peritoneal, endometrial, cervical, vulvar, and vaginal cancers) are distinct in their origin and etiology. Nonetheless, surgery coupled with chemo/radiation therapy has long been the standard of care and has yielded little patient benefit. Therefore, there is a need to understand these diseases better and identify novel approaches to targeting gynecological cancer.
While biologicals targeting angiogenesis, DNA repair and immunotherapy have shown promise in clinical studies, the metabolic targeting of gynecological cancer remains less explored. The aim of this Special Issue is to showcase original research articles, reviews, perspectives, clinical trials, and short communications highlighting metabolic features of gynecological cancer, with the objective to identify potential approaches that would lead to therapeutic interventions.
This Special Issue will help generate interest and provide insights into the metabolic targeting of gynecological cancers.
Dr. Abir Mukherjee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
